Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze
R
R
Department of Dermatology, Leiden University Medical center, The Netherlands.
Dreyling
M
M
D054697:Cytostatic Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011701:PUVA Therapy; D011379:Prognosis; D011878:Radiotherapy; D012176:Retinoids / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D054697:Cytostatic Agents; D012176:Retinoids; D013256:Steroids; D007372:Interferons